EMA regular press briefing on COVID-19

The European Medicines Agency (EMA) is resuming its fortnightly regular press briefings on Thursday 9 September 2021. The press briefings are organised to provide an update on EMA’s most recent COVID-19 activities.

Speakers:

• Marco Cavaleri (Head of Biological Health Threats and Vaccines Strategy)
• Fergus Sweeney (Head of Clinical Studies and Manufacturing Task Force)
• Georgy Genov (Head of Pharmacovigilance)

The press briefing will be moderated by Marie-Agnes Heine (Head of Communication Department).

EMA will still organise ad-hoc press conferences as necessary and appropriate.

The press briefing will be held in English. No translations will be provided.